Bajaj Healthcare has launched Ivejaj (Ivermectin) an Anti-Parasitic Drug now widely used in control & treatment for Covid-19 patients. The company has received approval from India's drug regulator, to manufacture and market ‘Ivejaj’ the oral Ivermectin approved medication in India for the treatment of COVID-19 from May 06, 2021. IVEJAJ Tablets comprising Ivermectin. Ivermectin is an Anti-Parasitic Drugs, which is used to control parasitic roundworm infections and curing parasitic infections, helps to improve health of Covid-19 Patients. It works by paralyzing and killing parasites.
Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.
